Antimicrobial susceptibility testing

麦克风RONAUT-S MDR MRGN-Screening

Phenotypic detection of clinically relevant resistance mechanisms, including confirmation of cephalosporinases and carbapenemases in Enterobacterales and non-fermenters

Lo más destacado

Phenotypic detection of clinically relevant cephalosporinases and carbapenemases

In recent years there has been an increase in multi-drug resistance (MDR) amongst gram-negative pathogens. This has impacted both hospital and community acquired infections.

The MICRONAUT-S MDR MRGN Screening plate provides an extended spectrum of critically important back-up antibiotics and meropenem screening concentrations for an improved detection of OXA-48-like type D carbapenemases.

It also offers an extended spectrum of antibiotics by introduction of the novel antibiotic combinations ceftazidime-avibactam and ceftolozane-tazobactam.

Características

麦克风plate for AST of multi-drug resistant gram-negative bacteria (MDR phenotype)

The MICRONAUT-S MDR MRGN Screening plate offers a range of features and benefits relating to the phenotypic detection of clinically relevant resistance mechanisms.

Resistance determination of all relevant gram-negative bacteria (Enterobacteria, Aeromonas, non-fermenters) against antibiotics and antibiotics combinations in a standard microdilution procedure
AST against the novel antibiotic combinations ceftazidime-avibactam and ceftolozane-tazobactam
Phenotypical detection of MBL (metallo-ß-lactamases) by resistance determination against meropenem as a mono substance and in combination with the divalent cationic chelator EDTA
Phenotypical detection of KPC (Klebsiella pneumoniaecarbapenemase) by resistance determination against meropenem as a mono substance and in combination with 3-Amino-Phenyl-Borate (3-APB)
Phenotypical detection of AMP-C (Aminopenicillin inactivating cephalosporinase) by the susceptibility testing with 3 extended spectrum cephalosporins and their combination with (3-APB)
Detection of OXA-48-like type D carbapenemases based on the determination of temocillin high-level resistance
Detection of low-level carbapenem resistance by introduction of meropenem screening concentrations
Analysis and interpretation after visual or automated reading according to EUCAST or CLSI standard

Please contact your local representative for availability in your country.

Not for sale in the USA. MERLIN Gesellschaft für mikrobiologische Diagnostika mbH – A Bruker Company (www.merlin-diagnostika.de)

Más información

更多的信息

1875130-brochure-merlin-micronaut-s-ivd-bruker-md-03-2020.pdf

Related products

merlin-micronaut-s-title

麦克风RONAUT-S MRSA GP

Based on the broth microdilution (BMD) procedure, the MICRONAUT-S MRSA/GP system provides the phenotypic detection of clinically relevant single or multi-resistance in staphylococci, enterococci and streptococci organisms. The susceptibility testing with highly effective back up antibiotics like ceftaroline, linezolid, tigecycline, daptomycin, and vancomycin offers therapeutic options in case of multi-drug resistance.

micronaut-s-ß-lactamases-carbapenemases-bruker-merlin-md-web

麦克风RONAUT-S ß-Lactamases & MICRONAUT-S Carbapenemases Detection

基于该标准的肉汤采用(BMD)我thod, the MICRONAUT-S ß-Lactamases and MICRONAUT-S Carbapenemases Detection systems are the only broth microdilution based systems that can differentiate between all Ambler class A (ESBL, KPC), class B (MBL), class C (AMP-C) and class D (OXA-48-like) cephalosporinases and / or carbapenemases.

merlin-micronaut-s anaerobes-title

麦克风RONAUT-S Anaerobes MIC

Based on the broth microdilution (BMD) procedure, the AST plate MICRONAUT-S Anaerobes MIC provides the tool for phenotypic detection of clinically relevant resistance mechanisms in anaerobic pathogens such as Clostridium spp., Bacteroides spp. and Peptostreptococcus spp.

micronaut-am-bruker-merlin-md-web

麦克风RONAUT-AM

The increasing prevalence and severity of fungal infections in healthcare scenarios requires a standardized routine antifungal susceptibility test (AFST) in the microbiology lab. The MICRONAUT-AM system uses MIC plates for the automated or manual susceptibility testing of yeast and cryptococci.

merlin-micronaut-s pneumococci and haemophilus mic-penicillin-title

麦克风RONAUT-S Pneumococci & Haemophilus MIC

基于该标准的肉汤采用(BMD)我thod, the routine antimicrobial susceptibility testing (AST) plate MICRONAUT-S Pneumococcus & Haemophilus MIC provides the phenotypic quantification of MIC values for 14 different antibiotics and antibiotic combinations commonly used for treatment of infections caused by Streptococcus pneumoniae and Haemophilus influenzae.

micronaut-s-pseudomonas-mic-bruker-merlin-md-web

麦克风RONAUT-S Pseudomonas MIC

基于该标准的肉汤采用(BMD)我thod, the antimicrobial susceptibility testing (AST) plate MICRONAUT-S Pseudomonas MIC provides the phenotypic quantification of MIC values for critically important antibiotics and back up antibiotics used for treatment of infections caused by non-fermenting pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia.

mic-strips-bruker-merlin-md-web

BMD MIC-Strips

BMD MIC-Strips are quantitative assays using the broth microdilution method, for determining the minimum inhibitory concentration (MIC) of antimicrobial agents (colistin, piperacillin-tazobactam, vancomycin/teicoplanin) against microorganisms to indicate appropriate patient treatment and for identifying resistance patterns.

merlin-micronaut-s-title

麦克风RONAUT IVD System

麦克风RONAUT IVD system offers a range of antibiotic resistance and specialty susceptibility testing

growth-media-bruker-merlin-md-web

Growth Media

For susceptibility testing of microorganisms

software-and-devices-bruker-merlin-md-web

Software and Devices

The software and devices available for using the MICRONAUT systems offer users a flexible degree of automation.

Contacto con un experto

Contact Information

Bruker Daltonics Offices

Get in touch with your local Bruker Daltonics office.

Find your local office

联系我们的专家

Get in touch with us for questions and solutions.